Search

Home > New FDA Approvals > 094 - Stannsoporfin for neonatal jaundice; Apadaz opioid approval; FDA on BPA rodent studies; Luzu cream for younger patients.
Podcast: New FDA Approvals
Episode:

094 - Stannsoporfin for neonatal jaundice; Apadaz opioid approval; FDA on BPA rodent studies; Luzu cream for younger patients.
Category: Science & Medicine
Duration: 00:10:13
Publish Date: 2018-02-26 07:00:00
Description:

February 26, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.

1:27 Mallinckrodt receives FDA acceptance of Stannsoporfin New Drug Application Filing https://www.prnewswire.com/news-releases/mallinckrodt-receives-fda-acceptance-of-stannsoporfin-new-drug-application-filing-300603227.html

3:02 FDA Approves KemPharm's benzhydrocodone, acetaminophen for short-term acute pain http://investors.kempharm.com/news-releases/news-release-details/kempharm-announces-fda-approval-apadaztm-benzhydrocodone-and

4:47 National Toxicology Program draft report on Bisphenol A https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm598100.htm

6:57 FDA approves the use of Luzu cream, an azole antifungal, in younger patients https://www.empr.com/news/luzu-snda-tinea-cruris-tinea-pedis-tinea-corporis-ringworm-jock-itch/article/746278/ 

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/

 
Total Play: 0